VIRUS AAV/IGF2, MÉTHODE DE TRAITEMENT GÉNÉTIQUE ET SON UTILISATION DANS DES MALADIES ASSOCIÉES AU MAUVAIS REPLIEMENT DES PROTÉINES TEL QUE LA MALADIE DE HUNTINGTON
The invention relates to the expression of two molecules in viral vectors AAV/IGF2-HA and AAV/IGF2, the associated method and use thereof in the amelioration of protein misfolding-related diseases, such as Huntington's disease, as presented in thein vivomodels infigure 11/19.